1. Exosomes-regulated lipid metabolism in tumorigenesis and cancer progression
    Leiguang Ye et al, 2023, Cytokine & Growth Factor Reviews CrossRef
  2. IFITM3-mediated activation of TRAF6/MAPK/AP-1 pathways induces acquired TKI resistance in clear cell renal cell carcinoma
    Se Un Jeong et al, 2024, Investigative and Clinical Urology CrossRef
  3. Exosome-Mediated Response to Cancer Therapy: Modulation of Epigenetic Machinery
    Mohammad Imran Khan et al, 2022, International Journal of Molecular Sciences CrossRef
  4. Extracellular vesicles in hematological malignancies: EV-dence for reshaping the tumoral microenvironment
    David Van Morckhoven et al, 2023, Frontiers in Immunology CrossRef
  5. The Role of Exosomes in the Progression and Therapeutic Resistance of Hematological Malignancies
    Haobing Wang et al, 2022, Frontiers in Oncology CrossRef
  6. DIA-Based Proteomics Identifies IDH2 as a Targetable Regulator of Acquired Drug Resistance in Chronic Myeloid Leukemia
    Wei Liu et al, 2022, Molecular & Cellular Proteomics CrossRef
  7. Roles of exosomes as drug delivery systems in cancer immunotherapy: a mini-review
    Zhen Fang et al, 2022, Discover Oncology CrossRef
  8. Emerging role of exosomes in hematological malignancies
    Sureshbabu Ram Kumar Pandian et al, 2022, Clinical and Experimental Medicine CrossRef
  9. Inhibition of casein kinase 2 induces cell death in tyrosine kinase inhibitor resistant chronic myelogenous leukemia cells
    Ondřej Mitrovský et al, 2023, PLOS ONE CrossRef
  10. The Role of CD36 in Cancer Progression and Its Value as a Therapeutic Target
    William W. Feng et al, 2023, Cells CrossRef
  11. Extracellular vesicles in the Chronic Myeloid Leukemia scenario: an update about the shuttling of disease markers and therapeutic molecules
    Simona Bernardi et al, 2024, Frontiers in Oncology CrossRef
  12. A Microchip For Exosome Isolation That Can Be Impregnated With Imatinib Simultaneously: An In Vitro Analysis
    Amir Monfaredan et al, 2024, Russian Open Medical Journal CrossRef
  13. Quantitative Proteomic Analysis of Plasma Exosomes to Identify the Candidate Biomarker of Imatinib Resistance in Chronic Myeloid Leukemia Patients
    Mei-Yong Li et al, 2021, Frontiers in Oncology CrossRef
  14. The Bone Marrow Immune Microenvironment in CML: Treatment Responses, Treatment-Free Remission, and Therapeutic Vulnerabilities
    Shaun David Patterson et al, 2023, Current Hematologic Malignancy Reports CrossRef
  15. Exosomes in Cancer Progression and Therapy Resistance: Molecular Insights and Therapeutic Opportunities
    Madita Wandrey et al, 2023, Life CrossRef
  16. Identification of exosomal microRNAs and related hub genes associated with imatinib resistance in chronic myeloid leukemia
    Arzu Zeynep Karabay et al, 2024, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef